ZEVRA THERAPEUTICS, INC. — Director's Dealing 2020

Jan 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2019-12-31

Reporting Person: Johnson Gordon K (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-31	Common Stock	P	10000	$0.39	Acquired	30000	Direct
2019-12-31	Common Stock	P	10000	$0.3884	Acquired	40000	Direct